JOURNAL ARTICLE

Weight‐loss drugs appear beneficial for patients with substance use disorders.

  • Published In: Brown University Psychopharmacology Update, 2025, v. 36, n. 2. P. 1 1 of 2

  • Database: Academic Search Ultimate 2 of 2

Abstract

Drugs in medication classes commonly used to treat type 2 diabetes and obesity appear to improve substance use outcomes in patients with opioid use disorder (OUD) and alcohol use disorder (AUD), a retrospective cohort study has found. Patients receiving these medications experienced significantly lower rates of opioid overdose and alcohol intoxication. Study results were published online Oct. 16, 2024, in Addiction. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Brown University Psychopharmacology Update. 2025/02, Vol. 36, Issue 2, p1
  • Document Type:Article
  • Subject Area:Pharmacy and Pharmacology
  • Publication Date:2025
  • ISSN:1068-5308
  • DOI:10.1002/pu.31260
  • Accession Number:181847842
  • Copyright Statement:Copyright of Brown University Psychopharmacology Update is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.